SIGA Technologies

$7.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.12 (-1.68%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SIGA and other stocks, options, and ETFs commission-free!

About SIGA

SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY. The listed name for SIGA is SIGA Technologies Inc. Common Stock.

CEO

Phillip Louis Gomez

Employees

Headquarters

New York, New York

Founded

1995

Market Cap

544.87M

Price-Earnings Ratio

17.38

Dividend Yield

—

Average Volume

202.41K

High Today

$7.19

Low Today

$6.99

Open Price

$7.08

Volume

325.06K

52 Week High

$8.10

52 Week Low

$3.96

Collections

SIGA Earnings

-$0.06

$0.06

$0.19

$0.31

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 4, After Hours